KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) EBT Margin (2020 - 2025)

Historic EBT Margin for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to 15.17%.

  • Organon's EBT Margin rose 20800.0% to 15.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.74%, marking a year-over-year decrease of 21000.0%. This contributed to the annual value of 20.08% for FY2024, which is 4900.0% up from last year.
  • Latest data reveals that Organon reported EBT Margin of 15.17% as of Q3 2025, which was up 20800.0% from 14.37% recorded in Q2 2025.
  • In the past 5 years, Organon's EBT Margin ranged from a high of 41.18% in Q4 2023 and a low of 5.27% during Q3 2023
  • In the last 5 years, Organon's EBT Margin had a median value of 15.8% in 2023 and averaged 20.74%.
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -186000bps in 2021, then skyrocketed by 231200bps in 2022.
  • Organon's EBT Margin (Quarter) stood at 14.72% in 2021, then soared by 157bps to 37.85% in 2022, then rose by 9bps to 41.18% in 2023, then decreased by -7bps to 38.19% in 2024, then tumbled by -60bps to 15.17% in 2025.
  • Its EBT Margin stands at 15.17% for Q3 2025, versus 14.37% for Q2 2025 and 6.68% for Q1 2025.